Acadia Healthcare/$ACHC
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Acadia Healthcare
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.
Ticker
$ACHC
Sector
Primary listing
Employees
22,346
Headquarters
Website
ACHC Metrics
BasicAdvanced
$1.8B
16.54
$1.18
0.89
-
Price and volume
Market cap
$1.8B
Beta
0.89
52-week high
$47.08
52-week low
$17.13
Average daily volume
2.4M
Financial strength
Current ratio
1.444
Quick ratio
1.2
Long term debt to equity
73.059
Total debt to equity
74.486
Interest coverage (TTM)
3.39%
Profitability
EBITDA (TTM)
626.819
Gross margin (TTM)
41.78%
Net profit margin (TTM)
3.29%
Operating margin (TTM)
13.59%
Effective tax rate (TTM)
15.99%
Revenue per employee (TTM)
$150,000
Management effectiveness
Return on assets (TTM)
4.52%
Return on equity (TTM)
3.69%
Valuation
Price to earnings (TTM)
16.544
Price to revenue (TTM)
0.544
Price to book
0.57
Price to tangible book (TTM)
2.36
Price to free cash flow (TTM)
-5.115
Free cash flow yield (TTM)
-19.55%
Free cash flow per share (TTM)
-3.814
Growth
Revenue change (TTM)
4.58%
Earnings per share change (TTM)
-61.31%
3-year revenue growth (CAGR)
8.90%
10-year revenue growth (CAGR)
7.43%
3-year earnings per share growth (CAGR)
-27.37%
10-year earnings per share growth (CAGR)
-2.51%
What the Analysts think about ACHC
Analyst ratings (Buy, Hold, Sell) for Acadia Healthcare stock.
Bulls say / Bears say
Acadia beat third-quarter estimates with adjusted EPS of $0.72 versus $0.67 and revenue up 4.4% to $851.6 million, demonstrating operational strength despite sector challenges (Investing.com).
The Board approved a $300 million share repurchase program on February 27, 2025, under which the company bought back $47.3 million in Q1 and $3.2 million in Q2, reflecting management’s confidence in the stock’s value (Nasdaq).
As of June 30, 2025, Acadia operates 274 behavioral health facilities with roughly 12,100 beds and expanded its comprehensive treatment center network to 174 locations across 33 states, serving over 74,000 patients daily (Business Wire).
Despite beating Q3 estimates, Acadia cut its full-year 2025 outlook to $3.28–3.30 billion in revenue and $2.35–2.45 in adjusted EPS, both below analyst forecasts of $3.31 billion and $2.47, due to weaker volumes, higher startup losses, and increased liability expenses (Investing.com).
The company is under investigation by the Department of Justice and SEC for potential wrongful patient detentions and fraudulent insurance claims, resulting in $84.5 million in legal costs in the first half of 2025 and a 71% drop in its share price over the past year (Financial Times).
Analysts are scaling back projections, with Mizuho lowering its price target to $32 from $37 and keeping a Neutral rating, noting weaker patient volumes and operational challenges as regulatory probes continue (Investing.com).
Data summarised monthly by Lightyear AI. Last updated on 8 Nov 2025.
ACHC Financial Performance
Revenues and expenses
ACHC Earnings Performance
Company profitability
ACHC News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Acadia Healthcare stock?
Acadia Healthcare (ACHC) has a market cap of $1.8B as of November 08, 2025.
What is the P/E ratio for Acadia Healthcare stock?
The price to earnings (P/E) ratio for Acadia Healthcare (ACHC) stock is 16.54 as of November 08, 2025.
Does Acadia Healthcare stock pay dividends?
No, Acadia Healthcare (ACHC) stock does not pay dividends to its shareholders as of November 08, 2025.
When is the next Acadia Healthcare dividend payment date?
Acadia Healthcare (ACHC) stock does not pay dividends to its shareholders.
What is the beta indicator for Acadia Healthcare?
Acadia Healthcare (ACHC) has a beta rating of 0.89. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.